Home >> Company >> RANBAXY LAB.
22 Feb, 2012
Ranbaxy launches cholesterol lowering drug in Australia
Ranbaxy Laboratories Ltd has launched blockbuster drug Atorvastatin in the Australian market. The company has introduced the product under the brand name, 'Trovas' and the drug will be available i...
Source: The Hindu Business Line
Click here for the full article.22 Feb, 2012
Ranbaxy launches generic version of Lipitor in Australia
The company said that this is the most prescribed statin in Australia
Source: Livemint.com
Click here for the full article.17 Feb, 2012
Buy Ranbaxy for the target prices of Rs 459/462/Higher with a stop loss of Rs 447: ICICIDirect
We said, "After strong gains, some profit-booking cannot be ruled out." The Index did cool down after the strong gains on the previous day, and ended 48 points or a marginal 0.2% lower. The
Source: Sify.com
Click here for the full article.02 Feb, 2012
Ranbaxy to get whistle-blower service
Ranbaxy will become the first Indian drug company to establish a whistle-blower programme for its employees. A soon-to-be appointed chief data reliability officer (CDRO) will be in charge. The
Source: Sify.com
Click here for the full article.02 Feb, 2012
Can Ranbaxy recover from its US debacle?
"We are pleased to have resolved this legacy issue with the FDA as we begin the next chapter in Ranbaxy's history," stated Arun Sawhney, CEO & Managing Director of India's biggest drug-maker
Source: Sify.com
Click here for the full article.31 Jan, 2012
Buy Ranbaxy: Sukhani
Sudarshan Sukhani of s2analytics is of the view that one can buy Ranbaxy for day trading.
Source: Moneycontrol.com
Click here for the full article.29 Jan, 2012
Ranbaxy's recurring FDA nightmare
The company has to give up 180-day marketing exclusivity rights for three generic drugs where it has the first-to-file (FTF) status
Source: Livemint.com
Click here for the full article.28 Jan, 2012
Ranbaxy likely to forgo 3 ANDAs on US consent decree
Ranbaxy Laboratories' troubles with the US Food & Drugs Administration (FDA) seem to have taken a new turn.
Source: DNA Money
Click here for the full article.27 Jan, 2012
Ranbaxy stock tanks on court filing in US
Ranbaxy shares dropped 6.62%-their biggest single-day fall since 21 March-to Rs 443.75 on a day the benchmark Sensex gained 0.88% to 17,228.3 points
Source: Livemint.com
Click here for the full article.27 Jan, 2012
Ranbaxy loses over 6% after US files 'ground-breaking' consent decree in court
Stock prices of Ranbaxy dropped nearly 7% on Friday after a consent decree was filed in a United States court that demands the drug company to make fundamental changes at its plants in the US and India.
Source: BloombergUTV.com
Click here for the full article.